EMLA Cream to be Taken Off the Market in the United States
AstraZeneca has confirmed that EMLA will be taken off the market in the US on November 15, 2002. EMLA is an anesthetic cream often used by insulin pumpers to numb the skin prior to inserting an insulin pump infusion set.
EMLA is being taken off the market because the packaging doesn't comply with the Poison Prevention Packaging Act. Once new, child-resistant packaging is designed and approved, EMLA will be reintroduced into the market. The expected re-release date is mid-2003.
Until that time, EMLA will only be available to hospitals for use in in-hospital settings. EMLA will no longer be available at pharmacies or to physicians for use in their offices.
If you use EMLA, now would be a good time to stock up.
As an alternative, EMLA users may want to consider ELA-Max, another topical anesthetic that doesn't require a prescription in the unites States. Information about ELA-Max is available at the Ferndale Labs web site or at via telephone (248) 548-0900.
For more information about the Poison Prevention Packaging Act, see the Consumer Products Safety Commission web site or call (301) 508-0608.
Source: Telephone conversation with AstraZeneca on October 31, 2002
1 November 2002
Last Updated: Thursday February 27, 2014 19:28:21
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.
This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents. Our mission is to provide education and support to families living with type 1 diabetes.
© Children with Diabetes, Inc. 1995-2018. Comments and Feedback.